Related Experiment Video
Updated: Jun 9, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Deprescribing strategies for proton pump inhibitors
Julia Young1, Jordan A Fuller, Corey M Guidry
1Julia Young, Jordan A. Fuller, and Corey M. Guidry are assistant professors at the University of Oklahoma College of Pharmacy in Oklahoma City, Okla. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Proton pump inhibitors (PPIs) effectively treat acid-related conditions but long-term use carries risks. This review outlines appropriate PPI use and strategies for deprescribing to minimize patient harm.
Area of Science:
- Gastroenterology
- Pharmacology
- Clinical Medicine
Background:
- Proton pump inhibitors (PPIs) are frequently prescribed for acid-related gastrointestinal disorders.
- While effective and well-tolerated for short-term use, long-term PPI therapy is linked to potential adverse events.
Purpose of the Study:
- To review the established indications for both short-term and long-term use of PPIs.
- To present evidence-based strategies for the deprescription of PPIs to reduce inappropriate utilization.
Main Methods:
- Literature review of clinical guidelines and research on PPI efficacy and safety.
- Analysis of studies focusing on PPI deprescribing interventions and patient outcomes.
Main Results:
- Appropriate indications for PPI use were identified, differentiating between short-term and long-term needs.
- Several deprescribing strategies were discussed, highlighting their potential to reduce PPI exposure.
Conclusions:
- Judicious use of PPIs based on clear indications is crucial.
- Implementing deprescribing strategies can mitigate risks associated with long-term PPI therapy and improve patient safety.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:46Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Antidepressant Drugs: MAOIs and Other Agents
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy